CRISPR-Cas9 Mediated Epigenetic Reprogramming of Cardiac Fibroblasts as a Therapeutic Strategy for Post-Infarction Myocardial Remodeling. International Journal of Medical Science Research and Development (ISCSITR-IJMSRD), [S. l.], v. 5, n. 2, p. 1–9, 2024. Disponível em: https://iscsitr.in/index.php/ISCSITR-IJMSRD/article/view/ISCSITR-IJMSRD_05_02_001.. Acesso em: 24 jul. 2025.